STRATA Skin Sciences patents cover excimer laser combination therapies
Investing.com - Arena Holdings (NYSE: AREN) reported first quarter EPS of $-1.04, $0.43 worse than the analyst estimate of $-0.61. Revenue for the quarter came in at $51.4M versus the consensus estimate of $48.5M.
Guidance
Arena Holdings sees FY 2023 revenue of $255.00M-$270.00M versus the analyst consensus of $260.00M.
Arena Holdings's stock price closed at $4.10. It is down -54.70% in the last 3 months and down -69.83% in the last 12 months.
Arena Holdings saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Arena Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Arena Holdings's Financial Health score is "fair performance".
Check out Arena Holdings's recent earnings performance, and Arena Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar